hsa-miR-203 enhances the sensitivity of leukemia cells to arsenic trioxide

Experimental and Therapeutic Medicine

Volumn 5, Issue 5, 2013, Pages 1315-1321

  He, Jin Hua ^a   Li, Yu Min ^b   Li, Yu Guang ^a   Xie, Xing Yi ^a   Wang, Li ^a   Chun, Shun Yi ^a   Cheng, Wu Jia ^a  

^a Panyu District Central Hospital   (China)

^b Minzu Hospital   (China)

Author keywords

Apoptosis; Arsenic trioxide; Chronic myelogenous leukemia; Eukaryotic expression vector; hsa miR 203

Indexed keywords

ARSENIC TRIOXIDE; BCR ABL PROTEIN; CASPASE 3; CASPASE 9; CYTOCHROME C; HSA MIR 203; MICRORNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DNA FRAGMENTATION; DNA TRANSFECTION; DOWN REGULATION; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE THERAPY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MUTAGENESIS; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; WESTERN BLOTTING;

EID: 84876537367     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.981     Document Type: Article

References (14)

1. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
2. Salim H, Akbar NS, Zong D, et al: miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence. Br J Cancer 107: 1361-1373, 2012.
3. Niederer F, Trenkmann M, Ospelt C, et al: Down-regulation of microRNA-34a* in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance. Arthritis Rheum 64: 1771-1779, 2012.
4. Chen Z, Chen GQ, Shen ZX, Sun GL, Tong JH, Wang ZY and Chen SJ: Expanding the use of arsenic trioxide: leukemias and beyond. Semin Hematol 39 (Suppl 1): 22-26, 2002.
5. Wu W: MicroRNA: potential targets for the development of novel drugs? Drugs R D 10: 1-8, 2010.
6. Greither T, Grochola LF, Udelnow A, Lautenschläger C, Würl P and Taubert H: Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 26: 73-80, 2010.
7. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I and Inazawa J: miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31: 766-776, 2010.
8. He JH, Li YG, Chen SY and Wang L: Construction of the eukaryotic expression vector targeting hsa-miR-203 and its effects on proliferation and apoptosis of K562 cell lines. Chin J Clin Lab Sci 30: 595-598, 2012 (In Chinese).
9. Li Y, Zhu XJ, Gu JY, et al: Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis. Cancer Sci 101: 948-954, 2010.
10. Melar-New M and Laimins LA: Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol 84: 5212-5221, 2010.
11. Ikenaga N, Ohuchida K, Mizumoto K, Yu J, Kayashima T, Sakai H, Fujita H, Nakata K and Tanaka M: MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma. Ann Surg Oncol 17: 3120-3128, 2010.
12. Yi R, Poy MN, Stoffel M and Fuchs E: A skin microRNA promotes differentiation by repressing 'stemness'. Nature 452: 225-229, 2008.
13. Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J and Malumbres M: Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13: 496-506, 2008.
14. Riedl SJ, Renatus M, Schwarzenbacher R, Zhou Q, Sun C, Fesik SW, Liddington RC and Salvesen GS: Structural basis for the inhibition of caspase-3 by XIAP. Cell 9: 791-800, 2001.